{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:19:05Z","timestamp":1791472745422,"version":"4.3.4"},"reference-count":151,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sichuan Provincial College Students Innovation and Entrepreneurship Training Program","award":["S202610626016"],"award-info":[{"award-number":["S202610626016"]}]},{"DOI":"10.13039\/501100004912","name":"Sichuan Agricultural University","doi-asserted-by":"publisher","award":["2521993028\/2025"],"award-info":[{"award-number":["2521993028\/2025"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2521993028\/2025"],"award-info":[{"award-number":["2521993028\/2025"]}],"id":[{"id":"https:\/\/ror.org\/0388c3403","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>RNA vaccines\u2014comprising linear mRNA, self-amplifying RNA, and circular RNA (circRNA)\u2014constitute a core next-generation platform for the prevention and control of viral diseases; among these, circRNA vaccines possess notable structural stability, yet their technical bottlenecks and application prospects in veterinary medicine have not been systematically reviewed. This review synthesizes current research on circRNA vaccine design, circularization strategies, translation mechanisms, delivery systems, and immunological outcomes, and compares their antiviral performance with that of linear mRNA vaccines. Owing to their covalently closed circular conformation, circRNA vaccines exhibit enhanced resistance to nucleases and superior thermal stability, enabling sustained transfection activity at ambient temperatures without reliance on strict cold chains; through cap-independent translation driven by internal ribosome entry sites or N6-methyladenosine modifications, and in conjunction with optimized circularization protocols and lipid nanoparticle carriers, circRNA vaccines elicit substantially higher antiviral IgG titers and durable antigen-specific T-cell memory relative to linear mRNA vaccines. These vaccines have been deployed against COVID-19, monkeypox, influenza, and livestock viral diseases, demonstrating strong adaptability to viral variants and compatibility with mucosal or needle-free administration routes. CircRNA vaccines are well suited for both emergency outbreak response and routine immunization programs; nevertheless, challenges persist, including low circularization efficiency for long sequences, elevated manufacturing costs, and inadequate quality control standards. Addressing these issues through improved production workflows and delivery technologies adapted to resource-limited settings will be critical to establishing circRNA vaccines as a pillar of livestock disease management and as a strategic reserve for emerging zoonotic threats.<\/jats:p>","DOI":"10.3390\/vaccines14090781","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:12:25Z","timestamp":1788783145000},"page":"781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5422-518X","authenticated-orcid":false,"given":"Dongjie","family":"Cai","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingling","family":"Li","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxu","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tian","sequence":"additional","affiliation":[{"name":"Sichuan Key Laboratory of Agricultural Animal Diseases and Veterinary Public Health, Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA Vaccines for Infectious Diseases\u2014Advances, Challenges and Opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.immuni.2023.11.009","article-title":"RNA Vaccines: A Transformational Advance","volume":"56","author":"Brown","year":"2023","journal-title":"Immunity"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yakovlev, V.A., Litvinova, V.R., Rudometova, N.B., Borgoyakova, M.B., Tigeeva, E.V., Starostina, E.V., Ivanova, K.I., Gudymo, A.S., Danilchenko, N.V., and Perfilyeva, O.N. (2025). Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A\/H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet Injection. Vaccines, 13.","DOI":"10.20944\/preprints202507.0123.v1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, C., Tang, X., Jiang, C., Zhang, Y., Han, B., Sun, Y., Guo, J., Peng, H., Wang, Z., and Wang, Y. (2025). Intradermal Delivery of SARS-CoV-2 RBD3-Fc mRNA Vaccines via a Needle-Free Injection System Induces Robust Immune Responses in Rats. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1530736"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101555","DOI":"10.1016\/j.xcrm.2024.101555","article-title":"Advancements in Clinical RNA Therapeutics: Present Developments and Prospective Outlooks","volume":"5","author":"Saw","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hsiung, K.-C., Chiang, H.-J., Reinig, S., and Shih, S.-R. (2024). Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions. Vaccines, 12.","DOI":"10.3390\/vaccines12121345"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e20240044","DOI":"10.1002\/EXP.20240044","article-title":"Exploring the Potential and Advancements of Circular RNA Therapeutics","volume":"5","author":"Wang","year":"2025","journal-title":"Exploration"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ahmadivand, S. (2025). Innovation in mRNA Vaccines and RNAi via Protein Nanocages. Vaccines, 13.","DOI":"10.3390\/vaccines13060653"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Le, T., Sun, C., Chang, J., Zhang, G., and Yin, X. (2022). mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases. Viruses, 14.","DOI":"10.3390\/v14020401"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of mRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-021-01339-1","article-title":"Clinical and Immunological Effects of mRNA Vaccines in Malignant Diseases","volume":"20","author":"Heine","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108015","DOI":"10.1016\/j.jbc.2024.108015","article-title":"mRNA Vaccine Sequence and Structure Design and Optimization: Advances and Challenges","volume":"301","author":"Jin","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-021-01311-z","article-title":"mRNA Vaccine: A Potential Therapeutic Strategy","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA Vaccine Development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-Amplifying RNA Vaccines for Infectious Diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Blakney, A.K., Ip, S., and Geall, A.J. (2021). An Update on Self-Amplifying mRNA Vaccine Development. Vaccines, 9.","DOI":"10.3390\/vaccines9020097"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/14760584.2015.965690","article-title":"Self-Replicating Alphavirus RNA Vaccines","volume":"14","author":"Ljungberg","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vallet, T., and Vignuzzi, M. (2025). Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development. Viruses, 17.","DOI":"10.3390\/v17040566"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40364-020-00204-5","article-title":"The Emerging Landscape of Circular RNAs in Immunity: Breakthroughs and Challenges","volume":"8","author":"Li","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s12276-024-01251-w","article-title":"Optimal Design of Synthetic Circular RNAs","volume":"56","author":"Choi","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.7150\/thno.24677","article-title":"Encoding Activities of Non-Coding RNAs","volume":"8","author":"Pang","year":"2018","journal-title":"Theranostics"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Guria, A., Sharma, P., Natesan, S., and Pandi, G. (2020). Circular RNAs\u2014The Road Less Traveled. Front. Mol. Biosci., 6.","DOI":"10.3389\/fmolb.2019.00146"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","article-title":"The Design and Synthesis of Circular RNAs","volume":"196","author":"Obi","year":"2021","journal-title":"Methods"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Robic, A., and K\u00fchn, C. (2020). Beyond Back Splicing, a Still Poorly Explored World: Non-Canonical Circular RNAs. Genes, 11.","DOI":"10.3390\/genes11091111"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, X., and Lu, Y. (2021). Circular RNA: Biosynthesis in Vitro. Front. Bioeng. Biotechnol., 9.","DOI":"10.3389\/fbioe.2021.787881"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41592-022-01487-2","article-title":"Best Practice Standards for Circular RNA Research","volume":"19","author":"Nielsen","year":"2022","journal-title":"Nat. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-020-01246-x","article-title":"CircRNA Inhibits DNA Damage Repair by Interacting with Host Gene","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: Metabolism, Functions and Interactions with Proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107641","DOI":"10.1016\/j.celrep.2020.107641","article-title":"Modulation of circRNA Metabolism by m6A Modification","volume":"31","author":"Dattilo","year":"2020","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","article-title":"N6-Methyladenosine Modification Controls Circular RNA Immunity","volume":"76","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2302191120","DOI":"10.1073\/pnas.2302191120","article-title":"Circular RNA Vaccine Induces Potent T Cell Responses","volume":"120","author":"Amaya","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41551-025-01344-5","article-title":"Small Circular RNAs as Vaccines for Cancer Immunotherapy","volume":"9","author":"Zhang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","article-title":"Engineering Circular RNA for Enhanced Protein Production","volume":"41","author":"Chen","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: Characterization, Cellular Roles, and Applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7150\/ijms.71840","article-title":"Advances in Circular RNA and Its Applications","volume":"19","author":"Zhao","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA Vaccines Manufacturing: Challenges and Bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11033-026-11455-0","article-title":"Process and Analytical Strategies for the Safe Production of mRNA Vaccines and Therapeutics","volume":"53","author":"Nowak","year":"2026","journal-title":"Mol. Biol. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Fu, Y., Ju, X., Zhang, F., Zhang, P., and He, M. (2024). Advances in Engineering Circular RNA Vaccines. Pathogens, 13.","DOI":"10.3390\/pathogens13080692"},{"key":"ref_41","first-page":"132809","article-title":"Purifying Circular RNA by Ultrafiltration","volume":"366","author":"Lu","year":"2024","journal-title":"Sep. Purif. Technol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102687","DOI":"10.1016\/j.omtn.2025.102687","article-title":"The Potential and Challenges of Circular RNA in the Development of Vaccines and Drugs for Emerging Infectious Diseases","volume":"36","author":"Chen","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2661120","DOI":"10.1080\/21645515.2026.2661120","article-title":"Self-Amplifying RNA (saRNA) and Circular RNA (circRNA) Vaccines: Progress, Evidence Gaps, and Translational Pathways for Durable and Scalable Immunization","volume":"22","author":"Fabian","year":"2026","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_44","unstructured":"Liu, M., Zhou, T., and Sheets, R. (2021). WHO Informal Consultation on Regulatory Considerations for Evaluation of the Quality, Safety and Efficacy of RNA-based Prophylactic Vaccines for Infectious Diseases, World Health Organization (WHO)."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32932","DOI":"10.1021\/jacs.5c09798","article-title":"A Computationally Optimized Ribonucleic Acid Circularization Strategy without Byproducts","volume":"147","author":"Chen","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA Vaccine in Disease Prevention and Treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"151095","DOI":"10.1016\/j.ijbiomac.2026.151095","article-title":"Nanovaccine Based on Chitosan Oligosaccharide-Polyethyleneimine Packaged circRNA Encoding Sigma C Proteins Elicits Protective Immunity against Novel Duck Reovirus in Ducks","volume":"351","author":"Tian","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liu, C., Zhai, W., Nie, W., Zhong, C., Diao, F., and Yin, B. (2025). Circular mRNA-LNP Vaccine Encoding Self-Assembled E2-TMD-Mi3 Nanoparticles Licit Enhanced CSFV-Specific Immunity over Commercial Subunit Vaccine. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1604677"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115419","DOI":"10.1016\/j.addr.2024.115419","article-title":"Advances in the Design and Delivery of RNA Vaccines for Infectious Diseases","volume":"213","author":"Lokras","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.omtn.2021.01.003","article-title":"Engineering Highly Efficient Backsplicing and Translation of Synthetic circRNAs","volume":"23","author":"Meganck","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e70414","DOI":"10.1002\/mco2.70414","article-title":"Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Laila, U.E., An, W., and Xu, Z.-X. (2024). Emerging Prospects of mRNA Cancer Vaccines: Mechanisms, Formulations, and Challenges in Cancer Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1448489"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2478\/jtim-2023-0122","article-title":"Circular RNA: A Promising New Star of Vaccine","volume":"11","author":"Xie","year":"2023","journal-title":"J. Transl. Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Jin, S., Zuo, Z., Liu, S., Xu, J., Yang, C., Wan, P., Xun, L., Luo, M., and Yang, F. (2025). Rational Design and Immunological Mechanisms of Circular RNA-Based Vaccines: Emerging Frontiers in Combating Pathogen Infection. Vaccines, 13.","DOI":"10.3390\/vaccines13060563"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bu, T., Yang, Z., Zhao, J., Gao, Y., Li, F., and Yang, R. (2025). Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010379"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gutjnl-2023-331742","article-title":"RNA-Based Therapies in Liver Metabolic Diseases","volume":"74","author":"Fontanellas","year":"2025","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7150\/thno.104698","article-title":"Optimized Circular RNA Vaccines for Superior Cancer Immunotherapy","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"115090","DOI":"10.1016\/j.intimp.2025.115090","article-title":"The Shift toward Nanovaccination: A Comprehensive Review of Advancing Nanovaccination for Combinatory Immune Regulation Therapies to Treat Infectious Diseases and Cancer","volume":"161","author":"Raziq","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"123446","DOI":"10.1016\/j.lfs.2025.123446","article-title":"The Effect of Proteasome in Heart Transplantation: From Mechanisms to Therapeutic Potential","volume":"364","author":"Zhou","year":"2025","journal-title":"Life Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102626","DOI":"10.1016\/j.omtn.2025.102626","article-title":"Mechanistic Insights into Circularization via Anabaena Group I Intron-Based Scarless Circular RNA","volume":"36","author":"Fan","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"109062","DOI":"10.1016\/j.bej.2023.109062","article-title":"Engineering Alkaline-Stable Barley Stripe Mosaic Virus-like Particles for Efficient Surface Modification","volume":"199","author":"Vaidya","year":"2023","journal-title":"Biochem. Eng. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, Adjuvants and Key Factors for Mucosal Immune Response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41929-025-01445-z","article-title":"Structural Insights and Engineering of the T4 Td Intron for Improved RNA Circularization","volume":"8","author":"An","year":"2025","journal-title":"Nat. Catal."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1038\/s41467-025-62607-y","article-title":"Self-Splicing RNA Circularization Facilitated by Intact Group I and II Introns","volume":"16","author":"Shen","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12951-026-04557-1","article-title":"Circular RNA Vaccines Encoding Fusion Proteins of Mpox Virus A35R-M1R and B6R-A29L Induce Robust and Durable Protective Immunity in Mice","volume":"24","author":"Chuai","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1093\/nar\/gkaa181","article-title":"Preferential Production of RNA Rings by T4 RNA Ligase 2 without Any Splint through Rational Design of Precursor Strand","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbt.2025.12.004","article-title":"Splint-Free Circular RNA Synthesis via RNA Secondary Structure\u2013Guided Ligation","volume":"91","author":"Kim","year":"2026","journal-title":"New Biotechnol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41422-026-01233-9","article-title":"IRES\u2013Cargo Interplay Structurally Modulates Circular RNA Translation","volume":"36","author":"Huang","year":"2026","journal-title":"Cell Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nsmb.2465","article-title":"HCV IRES Manipulates the Ribosome to Promote the Switch from Translation Initiation to Elongation","volume":"20","author":"Filbin","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"102587","DOI":"10.1016\/j.omtn.2025.102587","article-title":"Development and Comprehensive Evaluation of Scarless Circularization Systems for Circular RNA Therapeutics","volume":"36","author":"Chen","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105638","DOI":"10.1016\/j.ebiom.2025.105638","article-title":"Unlocking the Potential of Circular RNA Vaccines: A Bioinformatics and Computational Biology Perspective","volume":"114","author":"Liu","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1093\/infdis\/jiz553","article-title":"Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah Virus Challenge in Syrian Hamsters","volume":"221","author":"Lo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41551-024-01245-z","article-title":"Robust Genome and Cell Engineering via in Vitro and in Situ Circularized RNAs","volume":"9","author":"Tong","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wang, F., Li, W., Li, B., Xie, L., Tong, Y., and Xu, X. (2023). cRNAsp12 Web Server for the Prediction of Circular RNA Secondary Structures and Stabilities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043822"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/mr-2025-0062","article-title":"Ribozyme Biotechnology: Emerging Opportunities for Medical Applications in the RNA Therapeutics Era","volume":"6","author":"Zhang","year":"2026","journal-title":"Med. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lee, K.H., Lee, J., and Lee, S.-W. (2026). Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives. Vaccines, 14.","DOI":"10.3390\/vaccines14030221"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Bai, Y., Liu, D., He, Q., Liu, J., Mao, Q., and Liang, Z. (2023). Research Progress on Circular RNA Vaccines. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1091797"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cheng, F., Li, J., Hu, C., Bai, Y., Liu, J., Liu, D., He, Q., Jin, Q., Mao, Q., and Liang, Z. (2024). Study on the Characterization and Degradation Pattern of Circular RNA Vaccines Using an HPLC Method. Chemosensors, 12.","DOI":"10.3390\/chemosensors12070120"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1038\/s41467-024-53242-0","article-title":"A Single-Dose Circular RNA Vaccine Prevents Zika Virus Infection without Enhancing Dengue Severity in Mice","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1002\/mco2.153","article-title":"Circular RNA Vaccine, a Novel mRNA Vaccine Design Strategy for SARS-CoV-2 and Variants","volume":"3","author":"Su","year":"2022","journal-title":"MedComm"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e01775-23","DOI":"10.1128\/mbio.01775-23","article-title":"Circular RNA Vaccines with Long-Term Lymph Node-Targeting Delivery Stability after Lyophilization Induce Potent and Persistent Immune Responses","volume":"15","author":"Wan","year":"2024","journal-title":"mBio"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41587-025-02561-8","article-title":"Internal Cap-Initiated Translation for Efficient Protein Production from Circular mRNA","volume":"44","author":"Fukuchi","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"bbaf263","DOI":"10.1093\/bib\/bbaf263","article-title":"Artificial Intelligence-Driven circRNA Vaccine Development: Multimodal Collaborative Optimization and a New Paradigm for Biomedical Applications","volume":"26","author":"Zhao","year":"2025","journal-title":"Brief. Bioinform."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41541-024-00963-4","article-title":"CircRNA Based Multivalent Neuraminidase Vaccine Induces Broad Protection against Influenza Viruses in Mice","volume":"9","author":"Yue","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/CCID.S162724","article-title":"Current Trends in Needle-Free Jet Injection: An Update","volume":"11","author":"Barolet","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"126287","DOI":"10.1016\/j.ijpharm.2025.126287","article-title":"An Overview of Needle-Free Injection Technology in Human Vaccines","volume":"685","author":"Ma","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal Immunity and Vaccination Strategies: Current Insights and Future Perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Dotiwala, F., and Upadhyay, A.K. (2023). Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens. Vaccines, 11.","DOI":"10.3390\/vaccines11101585"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.immuni.2026.03.009","article-title":"Spatial Organization of Tissue-Resident Memory T Cells","volume":"59","author":"Burn","year":"2026","journal-title":"Immunity"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","article-title":"Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities\u2014Workshop Report","volume":"8","author":"Knisely","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"123331","DOI":"10.1016\/j.biomaterials.2025.123331","article-title":"Bioengineered Metastatic Cancer Nanovaccine with a TLR7\/8 Agonist for Needle-Free Intranasal Immunization","volume":"321","author":"Jung","year":"2025","journal-title":"Biomaterials"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41577-026-01273-7","article-title":"Harnessing Mucosal Immunity for Protective Vaccines","volume":"26","author":"Kwon","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101730","DOI":"10.1016\/j.nantod.2022.101730","article-title":"A Highly Efficient Needle-Free-Injection Delivery System for mRNA-LNP Vaccination against SARS-CoV-2","volume":"48","author":"Mao","year":"2023","journal-title":"Nano Today"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/cas.15542","article-title":"Induction of Potent Antitumor Immunity by Intradermal DNA Injection Using a Novel Needle-free Pyro-drive Jet Injector","volume":"114","author":"Inoue","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1038\/s41598-023-31199-2","article-title":"Intradermal Needle-Free Injection Prevents African Swine Fever Transmission, While Intramuscular Needle Injection Does Not","volume":"13","author":"Salman","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41541-022-00469-x","article-title":"A DNA Vaccine Targeting VEE Virus Delivered by Needle-Free Jet-Injection Protects Macaques against Aerosol Challenge","volume":"7","author":"Suschak","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The Clinical Progress of mRNA Vaccines and Immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid Nanoparticles for mRNA Delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between Endosomal Escape of LNP-mRNA and Loading into EVs for Transport to Other Cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e2307800120","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal Escape: A Bottleneck for LNP-Mediated Therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"101436","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why Do Lipid Nanoparticles Target the Liver? Understanding of Biodistribution and Liver-Specific Tropism","volume":"33","author":"Bremmell","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"113617","DOI":"10.1016\/j.jconrel.2025.113617","article-title":"Investigation of the Impact of Lipid Nanoparticle Compositions on the Delivery and T Cell Response of circRNA Vaccine","volume":"381","author":"Alshehry","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e2207841119","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid Nanoparticle-Mediated Lymph Node\u2013Targeting Delivery of mRNA Cancer Vaccine Elicits Robust CD8+ T Cell Response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cimb44030073","article-title":"Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line","volume":"44","author":"Yang","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-virology-111821-111145","article-title":"Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design Platform","volume":"11","author":"Zhu","year":"2024","journal-title":"Annu. Rev. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"123961","DOI":"10.1016\/j.ijpharm.2024.123961","article-title":"Polydopamine-Based Nano Adjuvant as a Promising Vaccine Carrier Induces Significant Immune Responses against Acinetobacter Baumannii-Associated Pneumonia","volume":"654","author":"Sabzi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Bian, X., Chen, J., Chen, X., Liu, C., Ding, J., Li, M., Zhang, X., Liu, Q., and Kong, Q. (2024). Construction and Evaluation of an Efficient Live Attenuated Salmonella Choleraesuis Vaccine and Its Ability as a Vaccine Carrier to Deliver Heterologous Antigens. Vaccines, 12.","DOI":"10.3390\/vaccines12030249"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11274-024-04065-0","article-title":"Important Role of Bacillus Subtilis as a Probiotic and Vaccine Carrier in Animal Health Maintenance","volume":"40","author":"Yuan","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"123541","DOI":"10.1016\/j.biomaterials.2025.123541","article-title":"Biodegradable Polymers with Tertiary Amines Enhance mRNA Delivery of Lipid Nanoparticles via Improved Endosomal Escape","volume":"324","author":"Zhao","year":"2026","journal-title":"Biomaterials"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of Lipid Nanoparticles for RNA Delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e08907","DOI":"10.1002\/advs.202508907","article-title":"Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA Modalities","volume":"12","author":"Casmil","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","article-title":"Exosome for mRNA Delivery: Strategies and Therapeutic Applications","volume":"22","author":"Iqbal","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"101266","DOI":"10.1016\/j.jbc.2021.101266","article-title":"Exosome-Mediated mRNA Delivery in Vivo Is Safe and Can Be Used to Induce SARS-CoV-2 Immunity","volume":"297","author":"Tsai","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.reth.2025.01.019","article-title":"Exosome-Based miRNA Delivery: Transforming Cancer Treatment with Mesenchymal Stem Cells","volume":"28","author":"Balaraman","year":"2025","journal-title":"Regen. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2400580","DOI":"10.1002\/smsc.202400580","article-title":"A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines","volume":"5","author":"Zhu","year":"2025","journal-title":"Small Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/s41467-023-38364-1","article-title":"Design of Bacteriophage T4-Based Artificial Viral Vectors for Human Genome Remodeling","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"105688","DOI":"10.1016\/j.antiviral.2023.105688","article-title":"T4 Bacteriophage Nanoparticles Engineered through CRISPR Provide a Versatile Platform for Rapid Development of Flu Mucosal Vaccines","volume":"217","author":"Li","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"101255","DOI":"10.1016\/j.coviro.2022.101255","article-title":"Bacteriophage T4 as a Nanovehicle for Delivery of Genes and Therapeutics into Human Cells","volume":"55","author":"Rao","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00284-021-02398-9","article-title":"Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses","volume":"78","author":"Anand","year":"2021","journal-title":"Curr. Microbiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2023-184312","article-title":"Development of Novel Lipid Nanoparticles and Virus-like Particles for In Vivo Engineering of Immune Cells for Targeted Cancer Therapy","volume":"142","author":"Han","year":"2023","journal-title":"Blood"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/17425247.2023.2228202","article-title":"Next-Generation Viral Nanoparticles for Targeted Delivery of Therapeutics: Fundamentals, Methods, Biomedical Applications, and Challenges","volume":"20","author":"Tan","year":"2023","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0113816128397187251003083256","article-title":"VLP-Based Cancer Therapy: Past, Present, and Future Prospects","volume":"32","author":"Raikar","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"102785","DOI":"10.1016\/j.copbio.2022.102785","article-title":"Virus-like Particles for Drug Delivery: A Review of Methods and Applications","volume":"78","author":"Ikwuagwu","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2026.05.012","article-title":"Virus-Like Particles: From Fundamental Concepts to Cutting-Edge Applications\u2014A Comprehensive Review of Production, Engineering, and Clinical Translation","volume":"253","author":"Lotfi","year":"2026","journal-title":"Methods"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"21154","DOI":"10.1021\/acsnano.5c06051","article-title":"Enhanced Nano-Vaccine Utilizing Biomineralized Virus-like Particles for Efficient Glioblastoma Immunotherapy via the Nose-To-Brain Delivery Pathway","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1038\/s41467-025-64181-9","article-title":"Engineering a Streamlined Virus-like Particle for Programmable Tissue-Specific Gene Delivery","volume":"16","author":"Han","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"115304","DOI":"10.1016\/j.addr.2024.115304","article-title":"Interactions between Nanoparticles and Lymphatic Systems: Mechanisms and Applications in Drug Delivery","volume":"209","author":"Tang","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"102640","DOI":"10.1016\/j.cis.2022.102640","article-title":"Nanoparticles: From Synthesis to Applications and Beyond","volume":"303","author":"Selmani","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Lee, J., Kang, S., Park, H., Sun, J.G., Kim, E.C., and Shim, G. (2023). Nanoparticles for Lymph Node-Directed Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020565"},{"key":"ref_133","first-page":"1973","article-title":"The Application of Nanoparticles in Cancer Immunotherapy: Targeting Tumor Microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2500139","DOI":"10.1002\/advs.202500139","article-title":"Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell-Derived Exosomes for Suppressing Tumor Progression and Metastasis","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Cho, H., Ahn, Y., Oh, T., Suh, J., and Chae, C. (2022). Non-Inferiority Field Study Comparing the Administrations by Conventional Needle-Syringe and Needle-Free Injectors of a Trivalent Vaccine Containing Porcine Circovirus Types 2a\/2b and Mycoplasma Hyopneumoniae. Vaccines, 10.","DOI":"10.3390\/vaccines10030358"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"127943","DOI":"10.1016\/j.vaccine.2025.127943","article-title":"Evaluation of the Immunization Effects of Needle-Free Injection for Four Common Porcine Vaccines","volume":"68","author":"Wu","year":"2025","journal-title":"Vaccine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1038\/s41598-023-43898-x","article-title":"Elucidation of Lipid Nanoparticle Surface Structure in mRNA Vaccines","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/tas\/txy094","article-title":"Frequencies and Severity of Injection-Site Lesions in Muscles from Rounds of Cow Carcasses","volume":"3","author":"Pfeiffer","year":"2019","journal-title":"Transl. Anim. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ikechukwu, P., and Agu, R. (2026). Advancing Needle-Free Jet Injectors for Global Vaccine Delivery. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18040417"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/2772434418666221114113036","article-title":"Vaccines: An Important Tool for Infectious Disease","volume":"18","author":"Saman","year":"2023","journal-title":"Recent Adv. Anti-Infect. Drug Discov."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/MDER.S491883","article-title":"A Pilot Open-Label Randomized Study to Evaluate the Safety, Tolerability, and Acceptability of the IntegriMedical\u00ae Needle Free Injection System versus a Conventional Needle-Based System in Healthy Volunteers, Using Normal Saline as a Placebo","volume":"17","author":"Pathan","year":"2024","journal-title":"Med. Devices Evid. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"100368","DOI":"10.1016\/j.eclinm.2020.100368","article-title":"Insulin Delivery with a Needle-Free Insulin Injector versus a Conventional Insulin Pen in Chinese Patients with Type 2 Diabetes Mellitus: A 16-Week, Multicenter, Randomized Clinical Trial (the FREE Study)","volume":"23","author":"Ji","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref_143","first-page":"1354","article-title":"Preparation and efficacy of a circRNA vaccine with herpes simplex virus type II gD as immunogen","volume":"41","author":"Zhang","year":"2025","journal-title":"Chin. J. Biotechnol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"116432","DOI":"10.1016\/j.celrep.2025.116432","article-title":"CircRNA Vaccine Encoding a Chimeric Immunogen of B6 and M1 Demonstrates Robust Immune Responses against MPXV","volume":"44","author":"Wu","year":"2025","journal-title":"Cell Rep."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Zhao, Y.-Y., Zhu, F.-M., Zhang, Y.-J., and Wei, H.Y. (2025). Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics. Vaccines, 13.","DOI":"10.3390\/vaccines13080821"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e202506330","DOI":"10.1002\/anie.202506330","article-title":"Integrated Chemoenzymatic Synthesis of the mRNA Vaccine Building Block N1-Methylpseudouridine Triphosphate","volume":"64","author":"Pfeiffer","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"128150","DOI":"10.1016\/j.vaccine.2025.128150","article-title":"A Single Ultra-Low Dose Self-Amplifying RNA Rabies Vaccine Confers Rapid and Complete Protection in Mice","volume":"73","author":"Zhao","year":"2026","journal-title":"Vaccine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/nar\/gkaa1256","article-title":"Characterizing and Circumventing Sequence Restrictions for Synthesis of Circular RNA in Vitro","volume":"49","author":"Rausch","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000001605","article-title":"GPC3-Based Circular RNA Vaccine Suppresses Hepatocellular Carcinoma Progression by Activating Adaptive Immune Responses","volume":"84","author":"Jiang","year":"2025","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"103002","DOI":"10.1016\/j.mtbio.2026.103002","article-title":"Transdermal Needle-Free Drug Delivery Approaches and Activation Mechanism","volume":"38","author":"Sasikala","year":"2026","journal-title":"Mater. Today Bio"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"n2744","DOI":"10.1136\/bmj.n2744","article-title":"mRNA Vaccines: Hope beneath the Hype","volume":"375","author":"Extance","year":"2021","journal-title":"BMJ-Br. Med. J."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:35:49Z","timestamp":1788784549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":151,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090781"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090781","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}